Ziopharm Oncology buy exploration
Start price
22.04.16
/
50%
€7.12
Target price
19.07.16
€10.10
Performance (%)
-43.45%
End price
19.07.16
€4.03
Summary
This prediction ended on 19.07.16 with a price of €4.03. Massive losses of -43.45% were the result for the BUY prediction by exploration. exploration has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Ziopharm Oncology | - | - | - | - |
| iShares Core DAX® | 0.271% | 2.504% | 3.327% | 50.436% |
| iShares Nasdaq 100 | 1.884% | 3.490% | 35.658% | 88.226% |
| iShares Nikkei 225® | 3.579% | 8.127% | 56.653% | 65.166% |
| iShares S&P 500 | 0.151% | 1.918% | 24.108% | 64.489% |
Comments by exploration for this prediction
In the thread Ziopharm Oncology diskutieren
Ziopharm: Biotechwerte werden wieder interessant
langfristig werden auch Biotechwerte wieder interessant.
(Stop Loss Kurs erreicht)


